XBiotech
XBIT· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -39.5% in FY2025
Sushma Shivaswamy is the CEO of XBiotech and was paid $571.0K in FY2025 (Dec).
Pay$100 in the stock at the end of FY21 → $22
Executives3
See all- 1John SimardFormer President & Chief Executive OfficerFY2023
- 2Sushma ShivaswamyPh.D. Interim Chief Executive Officer & Chief Scientific OfficerFY2025
- 3Angela HuDirector of FinanceFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allXBiotech paid its 2 named executives $816.4K in total in FY2025 (Dec). CEO Sushma Shivaswamy was paid $571.0K of that.
| Name | |||
|---|---|---|---|
| Sushma ShivaswamyPh.D. Interim Chief Executive Officer & Chief Scientific Officer | Not disclosed | ||
| Angela HuDirector of Finance | |||
| John SimardFormer President & Chief Executive Officer | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for XBiotech. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board2
See all- Jan-Paul Waldin, Esq.Lead independent director · 6 yr on the boardIndependentAudit (Chair), Compensation (Chair), Nominating and Corporate Governance (Chair)—Paid as an executive
- Peter Libby, M.D.Director · 5 yr on the boardIndependentAudit, Compensation, Nominating and Corporate Governance—Paid as an executive
The board of the latest proxy (FY2024).
Activity
Filings6
See all| Proxy statement | DEF 14A | Oct 2, 2026 | FY2025 |
| Annual report | 10-K | Mar 13, 2026 | FY2025 |
| Proxy statement | DEF 14A | Jul 7, 2025 | FY2024 |
| Annual report | 10-K | Mar 18, 2025 | FY2024 |
| Proxy statement | DEF 14A | May 1, 2024 | FY2023 |
| Annual report | 10-K | Mar 15, 2024 | FY2023 |